VVECTOR BIO
why choose us

VVECTOR BIO

VVector Bio, Inc. was founded in 2019 in Montreal, Canada to support R&D and preclinical studies in cell and gene therapy. The aim of the company is helping academic laboratories, hospitals, companies, and other institutions to bring faster to reality their innovative viral vector-based therapies in development. The company provides expert services to help you customize your viral vector carrier and also produce high virus vector yields for preclinical studies

image
Bridging Research and clinic

OUR SERVICES

Bridging Research and clinic

QUESTIONS AND ANSWERS

  • How do I select the type of viral vector needed for my research?

    AAV has been developed for the construction of viral vector candidates mainly for the purpose of gene therapy due to a number of attractive advantages. Advantages and drawbacks of AAV vector-mediated gene transfer are summarized below. Advantages: i) Great biosafety; the wild type AAVs are not known to cause disease in vivo, and most AAV genome elements have been removed for further security of gene delivery in vivo. ii) Low immunogenicity; AAV causes a mild immune response in vivo, providing support to their pathogenicity during gene delivery. iii) Broad range of infectivity. AAV can infect both dividing and quiescent cells in vivo, allowing gene delivery to a highly diverse range of cell types. 4) Stable expression. Long term gene delivery in vivo can be mediated by AAV. No integration into the genome.

  • How do I obtain a quotation and place an order for a pre-made or customized vector?

    Please contact us directly by email as indicated in our Home Page and we will provide a detailed response and personalized assistance to your research needs and inquiries.

  • The text of question?

    the text of answer

  • The text of question?

    the text of answer

  • The text of question?

    the text of answer

image image
image
image image
Testimonial

WHAT OUR CLIENTS SAY

Expert Team

TEAM MEMBERS

Alina Venereo Sanchez
Ph.D.

Founder and Chief Executive Officer

Amine Kamen
Ph.D.

Chief Scientific Officer

Omar Farnos Villar
Ph.D.

Operations Director

OUR ADVISORS

Michael M. Avedesian

Business Advisor

VVECTOR BIO, Bridging Research and Clinic